Novel tetracycline hybrids: synthesis, characterization, docking studies and in-vitro evaluation of antibacterial activity

Abstract Background The biggest menace in the world today is the infection caused by pathogenic bacteria in humans, where majority of the available antibiotics fail to provide therapeutic results due to resistance. The discovery of new molecules is the need of the hour and several research groups wo...

Full description

Saved in:
Bibliographic Details
Main Authors: Mansi Shah, Bhanubhai Suhagia, Sunita Goswami, Sneha Sagar, Arpit Patwari
Format: Article
Language:English
Published: SpringerOpen 2025-01-01
Series:Future Journal of Pharmaceutical Sciences
Subjects:
Online Access:https://doi.org/10.1186/s43094-025-00764-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832594907387133952
author Mansi Shah
Bhanubhai Suhagia
Sunita Goswami
Sneha Sagar
Arpit Patwari
author_facet Mansi Shah
Bhanubhai Suhagia
Sunita Goswami
Sneha Sagar
Arpit Patwari
author_sort Mansi Shah
collection DOAJ
description Abstract Background The biggest menace in the world today is the infection caused by pathogenic bacteria in humans, where majority of the available antibiotics fail to provide therapeutic results due to resistance. The discovery of new molecules is the need of the hour and several research groups worldwide are contributing to fight this scare. This work highlights our efforts towards discovering novel tetracycline hybrids that could serve as potent agents against several pathogenic bacterial strains causing infections. In total, ten compounds were synthesized which were chemically conjugates of Minocycline, an age-old tetracycline, and naturally occurring aldehydes and ketones available from the plant sources. Structural characterization of these compounds was done using Mass and 1HNMR. Molecular docking was carried out in order to predict the binding affinity of these compounds to various bacterial enzymes and known protein targets and to establish the structure–activity relationships. Molecular dynamic simulation studies and in silico pharmacokinetic and toxicity prediction studies were done to determine in silico pharmacokinetics and toxicity of compounds. In-vitro antibacterial activities were done using standard protocols against gram positive bacteria like Enterococcus faecalis, Staphylococcus aureus and gram-negative bacteria like Klebsiella pneumoniae, Pseudomonas aeruginosa and Escherichia coli. Results Promising results were obtained viz. compound 1,2 and 10 were found to be more potent against Staphylococcus aureus, compound 1 against Enterococcus faecalis, compound 2 and 3 against Escherichia coli, compound 7 and 8 against Pseudomonas aeruginosa and compound 7 against Klebsiella pneumoniae when compared with minocycline as standard compound. Conclusion All the synthesized compounds were screened for their anti-bacterial activity against gram positive and gram negative microorganisms. Amongst the ten synthesized minocycline hybrids, four minocycline hybrids exhibited potent antibacterial activity as compared to minocycline. These hybrids can serve as a promising lead compound for antibiotic drug discovery.
format Article
id doaj-art-7006bc6211b24d4d9104a08aeb6e1a63
institution Kabale University
issn 2314-7253
language English
publishDate 2025-01-01
publisher SpringerOpen
record_format Article
series Future Journal of Pharmaceutical Sciences
spelling doaj-art-7006bc6211b24d4d9104a08aeb6e1a632025-01-19T12:13:04ZengSpringerOpenFuture Journal of Pharmaceutical Sciences2314-72532025-01-0111111610.1186/s43094-025-00764-zNovel tetracycline hybrids: synthesis, characterization, docking studies and in-vitro evaluation of antibacterial activityMansi Shah0Bhanubhai Suhagia1Sunita Goswami2Sneha Sagar3Arpit Patwari4Faculty of Pharmacy, Dharamsinh Desai UniversityFaculty of Pharmacy, Dharamsinh Desai UniversityL.M. College of PharmacyNational Forensic Sciences UniversityPharmAce Research LaboratoryAbstract Background The biggest menace in the world today is the infection caused by pathogenic bacteria in humans, where majority of the available antibiotics fail to provide therapeutic results due to resistance. The discovery of new molecules is the need of the hour and several research groups worldwide are contributing to fight this scare. This work highlights our efforts towards discovering novel tetracycline hybrids that could serve as potent agents against several pathogenic bacterial strains causing infections. In total, ten compounds were synthesized which were chemically conjugates of Minocycline, an age-old tetracycline, and naturally occurring aldehydes and ketones available from the plant sources. Structural characterization of these compounds was done using Mass and 1HNMR. Molecular docking was carried out in order to predict the binding affinity of these compounds to various bacterial enzymes and known protein targets and to establish the structure–activity relationships. Molecular dynamic simulation studies and in silico pharmacokinetic and toxicity prediction studies were done to determine in silico pharmacokinetics and toxicity of compounds. In-vitro antibacterial activities were done using standard protocols against gram positive bacteria like Enterococcus faecalis, Staphylococcus aureus and gram-negative bacteria like Klebsiella pneumoniae, Pseudomonas aeruginosa and Escherichia coli. Results Promising results were obtained viz. compound 1,2 and 10 were found to be more potent against Staphylococcus aureus, compound 1 against Enterococcus faecalis, compound 2 and 3 against Escherichia coli, compound 7 and 8 against Pseudomonas aeruginosa and compound 7 against Klebsiella pneumoniae when compared with minocycline as standard compound. Conclusion All the synthesized compounds were screened for their anti-bacterial activity against gram positive and gram negative microorganisms. Amongst the ten synthesized minocycline hybrids, four minocycline hybrids exhibited potent antibacterial activity as compared to minocycline. These hybrids can serve as a promising lead compound for antibiotic drug discovery.https://doi.org/10.1186/s43094-025-00764-zTetracycline hybridsMolecular dockingIn-vitro antibacterial activity
spellingShingle Mansi Shah
Bhanubhai Suhagia
Sunita Goswami
Sneha Sagar
Arpit Patwari
Novel tetracycline hybrids: synthesis, characterization, docking studies and in-vitro evaluation of antibacterial activity
Future Journal of Pharmaceutical Sciences
Tetracycline hybrids
Molecular docking
In-vitro antibacterial activity
title Novel tetracycline hybrids: synthesis, characterization, docking studies and in-vitro evaluation of antibacterial activity
title_full Novel tetracycline hybrids: synthesis, characterization, docking studies and in-vitro evaluation of antibacterial activity
title_fullStr Novel tetracycline hybrids: synthesis, characterization, docking studies and in-vitro evaluation of antibacterial activity
title_full_unstemmed Novel tetracycline hybrids: synthesis, characterization, docking studies and in-vitro evaluation of antibacterial activity
title_short Novel tetracycline hybrids: synthesis, characterization, docking studies and in-vitro evaluation of antibacterial activity
title_sort novel tetracycline hybrids synthesis characterization docking studies and in vitro evaluation of antibacterial activity
topic Tetracycline hybrids
Molecular docking
In-vitro antibacterial activity
url https://doi.org/10.1186/s43094-025-00764-z
work_keys_str_mv AT mansishah noveltetracyclinehybridssynthesischaracterizationdockingstudiesandinvitroevaluationofantibacterialactivity
AT bhanubhaisuhagia noveltetracyclinehybridssynthesischaracterizationdockingstudiesandinvitroevaluationofantibacterialactivity
AT sunitagoswami noveltetracyclinehybridssynthesischaracterizationdockingstudiesandinvitroevaluationofantibacterialactivity
AT snehasagar noveltetracyclinehybridssynthesischaracterizationdockingstudiesandinvitroevaluationofantibacterialactivity
AT arpitpatwari noveltetracyclinehybridssynthesischaracterizationdockingstudiesandinvitroevaluationofantibacterialactivity